Preference, acceptability and implications of the rapid hepatitis C screening test among high-risk young people who inject drugs
Open Access
- 25 June 2014
- journal article
- research article
- Published by Springer Nature in BMC Public Health
- Vol. 14 (1) , 645
Abstract
People who inject drugs (PWID) are at highest risk for hepatitis C virus (HCV) infection, yet many remain unaware of their infection status. New anti-HCV rapid testing has high potential to impact this. Young adult (<30 years) active PWID were offered either the rapid OraQuick® or standard anti-HCV test involving phlebotomy, then asked to complete a short questionnaire about testing perceptions and preferences. Sample characteristics, service utilization, and injection risk exposures are assessed with the HCV testing choice as the outcome, testing preferences, and reasons for preference. Of 129 participants: 82.9% (n = 107) chose the rapid test. There were no significant differences between those who chose rapid vs. standard testing. A majority (60.2%) chose the rapid test for quick results; most (60.9%) felt the rapid test was accurate, and less painful (53.3%) than the tests involving venipuncture. OraQuick® anti-HCV rapid test was widely accepted among young PWID. Our results substantiate the valuable potential of anti-HCV rapid testing for HCV screening in this high risk population.Keywords
This publication has 58 references indexed in Scilit:
- Association between prescription drug misuse and injection among runaway and homeless youthDrug and Alcohol Dependence, 2014
- "To Share or Not to Share?" Serosorting by Hepatitis C Status in the Sharing of Drug Injection Equipment Among NHBS-IDU2 ParticipantsThe Journal of Infectious Diseases, 2013
- Screening for Hepatitis C Virus Infection in Adults: U.S. Preventive Services Task Force Recommendation StatementAnnals of Internal Medicine, 2013
- Injection Drug Use and Hepatitis C Virus Infection in Young Adult Injectors: Using Evidence to Inform Comprehensive PreventionClinical Infectious Diseases, 2013
- Hepatitis C in the United StatesNew England Journal of Medicine, 2013
- Testing for HCV Infection: An Update of Guidance for Clinicians and Laboratorians2013
- Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in ScotlandInternational Journal of Drug Policy, 2012
- Patterns of Prescription Drug Misuse among Young Injection Drug UsersJournal of Urban Health, 2012
- Emergency department patient perceptions and preferences on opt-in rapid HIV screening program componentsAIDS Care, 2009
- Diagnosis, management, and treatment of hepatitis C: An update # † ‡Hepatology, 2009